[Inhibitors of xanthine oxidoreductase].
Copyright policy )[Inhibitors of xanthine oxidoreductase].
Inhibitors of xanthine oxidoreductase decrease production of uric acid, thus they act as hypouricemic drugs. Allopurinol, a prototypical xanthine oxidoreductase inhibitor, has been widely prescribed for treatment of gout and hyperuricemia. However, severe side effects of allopurinol may occur in patients with renal insufficiency. Recently, novel nonpurine selective inhibitors of xanthine oxidoreductase have been developed as potential alternatives to allopurinol. They have different inhibition mechanisms, utilizing the enzyme structure and the reaction mechanism. Such variation of the inhibition mechanism affects/in vivo/hypouricemic effects of the inhibitors.
Gout, Pyridines, Xanthine Dehydrogenase, Allopurinol, Hyperuricemia, Gout Suppressants, Thiazoles, Febuxostat, Drug Design, Nitriles, Humans, Pyrazoles, Enzyme Inhibitors
Gout, Pyridines, Xanthine Dehydrogenase, Allopurinol, Hyperuricemia, Gout Suppressants, Thiazoles, Febuxostat, Drug Design, Nitriles, Humans, Pyrazoles, Enzyme Inhibitors
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!